SG Americas Securities LLC Makes New Investment in agilon health, inc. (NYSE:AGL)

SG Americas Securities LLC acquired a new stake in shares of agilon health, inc. (NYSE:AGLGet Rating) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 7,935 shares of the company’s stock, valued at approximately $173,000.

Other institutional investors also recently bought and sold shares of the company. Stratos Wealth Partners LTD. raised its position in agilon health by 1.3% in the second quarter. Stratos Wealth Partners LTD. now owns 38,554 shares of the company’s stock worth $842,000 after acquiring an additional 500 shares during the period. Cambridge Investment Research Advisors Inc. raised its position in shares of agilon health by 1.6% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 36,478 shares of the company’s stock valued at $796,000 after buying an additional 561 shares during the last quarter. Treasurer of the State of North Carolina grew its stake in agilon health by 1.6% during the first quarter. Treasurer of the State of North Carolina now owns 61,489 shares of the company’s stock valued at $1,559,000 after acquiring an additional 980 shares in the last quarter. Level Financial Advisors Inc. bought a new stake in agilon health in the 2nd quarter valued at $25,000. Finally, First Horizon Advisors Inc. increased its holdings in shares of agilon health by 772.7% in the first quarter. First Horizon Advisors Inc. now owns 1,213 shares of the company’s stock worth $31,000 after purchasing an additional 1,074 shares during the last quarter.

agilon health Stock Performance

AGL stock opened at $18.98 on Friday. The firm has a 50-day simple moving average of $21.67 and a two-hundred day simple moving average of $21.66. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.48 and a current ratio of 2.48. agilon health, inc. has a one year low of $14.36 and a one year high of $28.36. The firm has a market cap of $7.82 billion, a price-to-earnings ratio of -73.00 and a beta of 0.93.

Insider Buying and Selling

In other agilon health news, insider Benjamin Kornitzer sold 8,094 shares of agilon health stock in a transaction on Friday, September 9th. The shares were sold at an average price of $23.08, for a total value of $186,809.52. Following the transaction, the insider now directly owns 10,853 shares of the company’s stock, valued at $250,487.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other agilon health news, insider Benjamin Kornitzer sold 8,094 shares of the stock in a transaction dated Friday, September 9th. The stock was sold at an average price of $23.08, for a total value of $186,809.52. Following the completion of the sale, the insider now directly owns 10,853 shares in the company, valued at $250,487.24. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Benjamin Shaker sold 29,548 shares of the business’s stock in a transaction dated Thursday, October 20th. The stock was sold at an average price of $20.37, for a total value of $601,892.76. Following the sale, the insider now owns 25,625 shares in the company, valued at approximately $521,981.25. The disclosure for this sale can be found here. Insiders sold a total of 72,716 shares of company stock worth $1,578,866 in the last 90 days. 3.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on AGL shares. Wells Fargo & Company increased their price target on agilon health from $23.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, August 8th. SVB Leerink reduced their price objective on agilon health from $33.00 to $30.00 and set an “outperform” rating on the stock in a report on Friday, November 4th. Truist Financial lowered their target price on agilon health from $33.00 to $29.00 and set a “buy” rating for the company in a report on Wednesday, September 7th. The Goldman Sachs Group initiated coverage on agilon health in a research note on Monday, September 12th. They set a “buy” rating and a $38.00 price target on the stock. Finally, TheStreet lowered shares of agilon health from a “c-” rating to a “d+” rating in a research note on Thursday, August 18th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $30.57.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.